Search results for Glp-1 Drugs

GLP-1 drugs reduce risk of major adverse cardiovascular events

New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death over a sustained period of time.

GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers

WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers. "GLP-1 receptor agonists have never been just glucose-lower...

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...

GLP-1s Now Linked To Lower Risk Of 4 Different Cancerous Tumors

What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...

GLP-1 Drugs May Improve Breast Cancer Outcomes

WEDNESDAY, May 13, 2026 — Popular GLP-1 medications may be linked to better long-term outcomes for some breast cancer patients. Previous research has shown breast cancer survivors...

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual me...

GLP-1 Drugs May Cut Risk of Heart Attack, Stroke, and Death by About 13 Percent

Learn how GLP-1 drugs may protect the heart by lowering inflammation, improving blood vessels, and reducing key risk factors.

GLP1 medications are here to stay; K.U. endocrinologist says

Millions of people are using or have used GLP1 drugs including Ozempic, Wegovy and Mounjaro to combat diabetes and obesity.

How safe are GLP-1 drugs, really?

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose significant weight, blood sugar improves, and for the first...

GLP-1 Weight Loss Linked To Dramatically Lower Risk of Sleep Apnea, Kidney Disease and More

New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related di...

Best GLP-1 Drug on the Market Is Even Better Than We Knew

GLP-1 Drugs Offer Real Hope for People With Pain or Addiction

By Dr. Lynn WebsterIn Greek mythology, the goddess Panacea carried a potion that could heal any disease. It’s a seductive image, and it’s how GLP-1 drugs can start to feel as repor...

GLP-1s reduced ED visits, infections and revisions in orthopedics

NEW ORLEANS — Results presented here showed GLP-1 receptor agonists may be associated with lower ED utilization and a reduction in surgical site infections and revisions for a rang...

Popular Weight-Loss Drugs Found To Cut Heart Attack and Stroke Risk

A large-scale analysis suggests that GLP-1 receptor agonists may do more than manage weight or blood sugar. New research suggests that GLP-1 weight loss drugs may provide lasting p...

Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk

After winning the battle for injectable obesity medicines, Lilly hopes Foundayo can help it catch up in the oral market, where Novo has a three-month lead.

GLP-1 Drugs Target the Roots of Dementia

A comprehensive review of 30 studies finds that GLP-1 receptor agonists are effective at tackling the biological drivers of Alzheimer’s disease.

GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study

GLP-1 drugs are often praised for their metabolic benefits, including improved blood sugar control and weight reduction. However, in patients with liver cirrhosis, these benefits m...

GLP-1 Users May Experience A Surprising Life-Saving Benefit That Has Nothing To Do With Weight Loss

A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.

As demand for GLP-1s surges, healthy habits are still key

About 1 in 8 U.S. adults say they are taking a GLP-1 drug, according to a recent survey.

GLP-1 and dual GLP-1 / GIP drugs help lose body fat while preserving lean mass

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agoni...

Lilly's Foundayo enters oral GLP-1 market

Lilly's FDA approval of Foundayo puts it in direct competition with Novo Nordisk's oral Wegovy. Back home, Indian companies are lining up their own GLP-1 bets from generics to nove...

GLP-1s may not raise DKA, pancreatitis risk in type 1 diabetes

LAS VEGAS — GLP-1 receptor agonists may not raise the risk for diabetic ketoacidosis or pancreatitis among adults with type 1 diabetes, according to the findings from a single-cent...

Doctors Reveal The Most Common Side Effects Of GLP-1s — And How To Manage Them

Ozempic, Wegovy and other GLP-1 medications are popular but can cause unwanted health concerns.

Experts warn of dosing issues with GLP-1 weight loss drugs

While many patients are seeing life-changing results with GLP-1 medications, doctors say the medications can also come with risks if they are not dosed properly.